-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW) Short Interest Update
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW) Short Interest Update
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) saw a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,300 shares, a decline of 13.3% from the July 31st total of 1,500 shares. Based on an average trading volume of 15,800 shares, the days-to-cover ratio is currently 0.1 days.
Intelligent Medicine Acquisition Price Performance
Shares of Intelligent Medicine Acquisition stock remained flat at $0.10 on Wednesday. The company had a trading volume of 10,900 shares, compared to its average volume of 18,363. Intelligent Medicine Acquisition has a 1 year low of $0.03 and a 1 year high of $0.60.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Company Profile
(Get Rating)
Intelligent Medicine Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.See Also
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDW)
- Crowdstrike Stock Retraces, As Earnings Sober Expectations
- Will The Institutions Buy The Dip In Ambarella Stock?
- PVH Corporation Is On Track For Capital Returns
- Can Pinterest Rally On Support From Big Investor With Conviction?
- Chargepoint Rallies, Despite Weaker Earnings
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) saw a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,300 shares, a decline of 13.3% from the July 31st total of 1,500 shares. Based on an average trading volume of 15,800 shares, the days-to-cover ratio is currently 0.1 days.
智能醫藥收購公司(納斯達克代碼:IQMDW-GET Rating)8月份空頭股數股價大幅下跌。截至8月15日,空頭股數共有1,300股,較7月31日的1,500股下跌13.3%。以15,800股的平均成交量計算,目前天數與回補比率為0.1天。
Intelligent Medicine Acquisition Price Performance
智能醫療採辦性價比
Shares of Intelligent Medicine Acquisition stock remained flat at $0.10 on Wednesday. The company had a trading volume of 10,900 shares, compared to its average volume of 18,363. Intelligent Medicine Acquisition has a 1 year low of $0.03 and a 1 year high of $0.60.
週三,智能醫藥收購股票的股價持平於0.10美元。該公司成交量為10,900股,而其平均成交量為18,363股。智能醫藥收購的一年低點為0.03美元,一年高位為0.60美元。
Intelligent Medicine Acquisition Company Profile
智能醫藥收購公司簡介
(Get Rating)
(獲取評級)
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDW)
- Crowdstrike Stock Retraces, As Earnings Sober Expectations
- Will The Institutions Buy The Dip In Ambarella Stock?
- PVH Corporation Is On Track For Capital Returns
- Can Pinterest Rally On Support From Big Investor With Conviction?
- Chargepoint Rallies, Despite Weaker Earnings
- 免費獲取StockNews.com關於智能醫療收購的研究報告(IQMDW)
- CrowdStrike股價回落,盈利超出預期
- 這些機構會在安巴雷拉入股抄底嗎?
- PVH公司有望實現資本回報
- Pinterest能否堅定地獲得大投資者的支持?
- ChargePoint上漲,儘管收益疲軟
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受《智能醫藥採購日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對智能醫藥收購和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧